Jushi Holdings (JUSHF) Operating Expenses (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Operating Expenses came in at $28.3 million in Q1 2026, up 2.34% year-on-year from $27.6 million in Q1 2025, and up 1.66% on a QoQ basis from $27.8 million in Q4 2025.
Jushi Holdings (JUSHF) Operating Expenses (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Operating Expenses data on file, last reported at $28.3 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 2.34% year-over-year to $28.3 million in Q1 2026; TTM through Mar 2026 was $109.8 million, a 2.71% increase from a year earlier, with the FY2025 full-year figure at $109.1 million, up 1.57% from the prior year.
- Operating Expenses for Q1 2026 stood at $28.3 million, up from $27.8 million in the prior quarter.
- Over the last five years, Operating Expenses for JUSHF reached as high as $161.2 million in Q4 2022 and fell as low as $24.2 million in Q2 2024.
- Historically, Operating Expenses has averaged $40.0 million across 5 years, with a median of $28.2 million in 2024.
- Across the five-year window, Operating Expenses surged 252.32% in 2022 and tumbled 79.06% in 2023, its largest moves.
- Year by year, Operating Expenses stood at $161.2 million in 2022, then tumbled by 79.06% to $33.8 million in 2023, then decreased by 19.27% to $27.2 million in 2024, then gained by 2.14% to $27.8 million in 2025, then advanced by 1.66% to $28.3 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $28.3 million in Q1 2026, $27.8 million in Q4 2025, and $28.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 455.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Jushi Holdings | 79.96 Mn | 40.26 Mn | 29.88 Mn | 28.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.29 Mn |
| Dec 31, 2025 | 27.83 Mn |
| Sep 30, 2025 | 28.33 Mn |
| Jun 30, 2025 | 25.32 Mn |
| Mar 31, 2025 | 27.65 Mn |
| Dec 31, 2024 | 27.25 Mn |
| Sep 30, 2024 | 27.82 Mn |
| Jun 30, 2024 | 24.16 Mn |
| Mar 31, 2024 | 28.21 Mn |
| Dec 31, 2023 | 33.75 Mn |
| Sep 30, 2023 | 25.69 Mn |
| Jun 30, 2023 | 27.15 Mn |
| Mar 31, 2023 | 32.45 Mn |
| Dec 31, 2022 | 161.16 Mn |
| Sep 30, 2022 | 78.19 Mn |
| Jun 30, 2022 | 38.75 Mn |
| Mar 31, 2022 | 37.31 Mn |
| Dec 31, 2021 | 45.74 Mn |
| Sep 30, 2021 | 25.15 Mn |
| Jun 30, 2021 | 26.36 Mn |